Last10K.com

Theravance Biopharma, Inc. (TBPH) SEC Filing 8-K Material Event for the period ending Monday, November 13, 2017

Theravance Biopharma, Inc.

HISTORY TOOLS
CIK: 1583107 Ticker: TBPH

View differences made from one to another to evaluate Theravance Biopharma, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Theravance Biopharma, Inc..

Continue

Assess how Theravance Biopharma, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Theravance Biopharma, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: TBPH
CIK: 1583107
Form Type: 8-K Corporate News
Accession Number: 0001104659-18-049002
Submitted to the SEC: Thu Aug 02 2018 8:30:17 AM EST
Accepted by the SEC: Thu Aug 02 2018
Period: Monday, November 13, 2017
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. New Agreement

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/tbph/0001104659-18-049002.htm